Related Experiment Video

Updated: Jun 25, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.7K

Interventions for Proliferative Vitreoretinopathy

Wilson X Wang1, Maggie Xing1, Rajendra S Apte1

  • 1John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri.

JAMA Ophthalmology
|May 23, 2024
PubMed
Abstract

Insights

Pharmacologic interventions show limited efficacy in preventing proliferative vitreoretinopathy. Currently available options lack high-quality evidence for effective prevention of this condition.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Pharmacology

Background:

  • Proliferative vitreoretinopathy (PVP) is a significant cause of vision loss following retinal detachment surgery.
  • Current management strategies often involve surgical intervention, but prevention remains a challenge.

Purpose of the Study:

  • To evaluate the efficacy of pharmacologic interventions in preventing proliferative vitreoretinopathy.
  • To assess the quality of evidence supporting existing pharmacological options for PVP prevention.

Main Methods:

  • Systematic review of clinical trials and observational studies.
  • Analysis of studies investigating pharmacological agents for PVP prevention.

Main Results:

  • Limited high-quality evidence supports the efficacy of current pharmacologic interventions for PVP prevention.
  • Further research is needed to identify effective pharmacological treatments.

Conclusions:

  • Available pharmacological options have not demonstrated robust efficacy in preventing proliferative vitreoretinopathy.
  • Development of evidence-based pharmacologic strategies is crucial for improving patient outcomes.

More Related Videos

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.8K
Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care11:06

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

2.7K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
430